Search

Search Constraints

You searched for: Author/Creator Angenendt, Linus

Search Results

2. Dose escalation and expansion phase I studies with the tumour-targeting antibody-tumour necrosis factor fusion protein L19TNF plus doxorubicin in patients with advanced tumours, including sarcomas. (June 2021)

4. Low‐density lipoprotein receptor (LDLR) is an independent adverse prognostic factor in acute myeloid leukaemia. (8th June 2020)

5. Phase I study of F16IL2 antibody–cytokine fusion with very low‐dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation. (22nd February 2021)

6. Potentiating the activity of rituximab against mantle cell lymphoma in mice by targeting interleukin-2 to the neovasculature. Issue 7 (July 2015)

8. Reptin drives tumour progression and resistance to chemotherapy in nonsmall cell lung cancer. Issue 1 (12th July 2018)